Elsevier Provides Free Clinical Reference Support for Japan Earthquake Relief Efforts

New Radiation Sickness Resource Pages Added to MD Consult and First Consult; Company Participating in National Library of Medicine Emergency Access Initiative

TOKYO, March 25, 2011 - Elsevier (www.elsevier.com/), a world leader in health care and
medical publishing and online solutions, today announced that following
the devastating earthquake and tsunami that struck Japan on March 11,
the company is providing free access to its primary online clinical
reference tools - MD Consult and First Consult - to all IPs originating
from Japan. Free access will be available through April, 2011. This
effort is part of a new initiative to provide easily accessible focused
resources in response to world events that present difficult medical
challenges.

MD Consult (www.mdconsult.com/) is an authoritative combination
of clinically relevant information to give medical professionals an answer
to their clinical questions, stay abreast of recent developments, and
educate patients, resulting in better patient care and improved outcomes.
First Consult (www.firstconsult.com/) is Elsevier's point-of-care
content that is integrated within MD Consult and leverages evidence-based
medical information to deliver answers that are trusted, quick, and
accessible.

MD Consult has also added a recommended resource topic page
for Radiation Sickness
(www.mdconsult.com/recommended-results/RADIATIONSICKNESS.lp), which
is linked from www.mdconsult.com.

If access to a desktop computer is problematic, MD Consult has
a mobile version, and First Consult has an iPhone/iPad app (
itunes.apple.com/us/app/first-consult/id399677784?mt=8) that provides
offline access to First Consult's content in areas that have limited or no
internet connectivity.

Emergency Access Initiative

Elsevier is also providing free online access to medical
information for healthcare professionals in Japan through the Emergency
Access Initiative (EAI) (eai.nlm.nih.gov/docs/captcha/test.pl?url=), a
partnership of the National Library of Medicine and the
Professional/Scholarly Publishing Division of the Association of American
Publishers and other publishers. EAI provides temporary free access to
full-text articles from major biomedicine titles to healthcare professionals,
librarians and the public affected by disasters. The idea for EAI was
proposed in the aftermath of 9/11, but its first real use was in response to
last year's earthquake in Haiti.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. The company works in partnership
with the global science and health communities to publish more than 2,000
journals, including The Lancet (www.thelancet.com) and Cell
(www.cell.com), and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
SciVerse ScienceDirect (www.sciencedirect.com), SciVerse Scopus
(www.scopus.com), Reaxys (www.reaxys.com), MD Consult
(www.mdconsult.com) and Nursing Consult (www.nursingconsult.com
), which enhance the productivity of science and health professionals, and
the SciVal suite (www.scival.com) and MEDai's Pinpoint Review
(www.medai.com), which help research and health care institutions
deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier (
www.elsevier.com) employs 7,000 people worldwide. The company is part
of Reed Elsevier Group PLC (www.reedelsevier.com), a world-leading
publisher and information provider, which is jointly owned by Reed Elsevier
PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam),
REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

    Media Contact
    Tom Reller
    Vice President, Global Corporate Relations
    Elsevier
    +1-215-239-3508
    T.Reller@Elsevier.com

Media Contact: Tom Reller, Vice President, Global Corporate Relations, Elsevier, +1-215-239-3508, T.Reller at Elsevier.com